To enhance service speed and avoid tariff delays, we've opened a US warehouse. All US orders ship directly from our US facility.
| Cat. No. | Product Name | Field of Application | Chemical Structure |
|---|---|---|---|
| DC46981 | 4-Nitroquinoline 1-oxide |
4-Nitroquinoline 1-oxide (4-Nitroquinoline-N-oxide, 4-NQO, 4NQO, 4Nqo, NQO, NQNO) is a highly carcinogenic model chemical that induces mutations in bacteria, fungi, and animals through the formation of bulky purine adducts.
More description
|
|
| DC42705 | BRD0418 Featured |
Novel upregulator of TRIB1 expression, leading to reprogramming of hepatic lipoprotein metabolism from lipogenesis to scavenging
More description
|
|
| DC42693 | CL5D Featured |
Novel potent SIRT6 activator against whole histone substrate
More description
|
|
| DC42745 | JR14a Featured |
Novel potent and selective antagonist of human Complement C3a receptor
More description
|
|
| DC42642 | Autogramin-1 Featured |
Novel autophagy inhibitor, selectively targeting cholesterol transfer protein GRAM domain-containing protein 1A (GRAMD1A), and directly competing with cholesterol binding to the GRAMD1A StART domain
More description
|
|
| DC42606 | XS018661 Featured |
The first-in-class dual inhibitor of ENL (Kd = 754 ± 45 nM) and its paralog AF9 (Kd = 523 ± 53 nM)
More description
|
|
| DC42580 | Takeda103A Featured |
Novel potent inhibitor of the GRK2--dependent bovine tubulin oxidation
More description
|
|
| DC22156 | ML-191 Featured |
ML-191 is a potent, selective GPR55 antagonist with 160 nM potency for GPR55 and >100-fold selectivity against GPR35, CB1 and CB2.
More description
|
|
| DC42820 | CYM51010(ML335) Featured |
CYM51010 is a biased ligand of μ-opioid receptor – δ-opioid receptor heterodimers. CYM51010 exhibits anti-nociceptive activity similar to morphine, but with a decreased levels of tolerance development and withdrawal symptoms.
More description
|
|
| DC42664 | ML-179 Featured |
ML-179 is a potent inverse agonist of liver receptor homolog-1 (LRH-1) (IC50 = 320 nM) with maximum efficacy of 40% repression.
More description
|
|
| DC33231 | PF9601N Featured |
PF9601N is a selective and potent monoamine oxidase B inhibitor that exhibit anti-Parkinsonian effects in several models of PD.
More description
|
|
| DC8951 | 4-NITROCATECHOL Featured |
|
|
| DC8858 | Bafilomycin A1(Baf-A1) Featured |
Bafilomycin A1 is a vacuolar H+-ATPase inhibitor with IC50 of 0.44 nM.
More description
|
|
| DC8603 | SR 49059 Featured |
Potent and selective non-peptide vasopressin V1A receptor antagonist; devoid of agonist activity. Displays high affinity and efficacy at both rat (KI=1.6 nM) and human (KI -1.1 - 6.3 nM) V1A receptors.
More description
|
|
| DC4150 | Menotrophin Featured |
|
|
| DC23894 | HPI-1 Featured |
HPI-1 is a Hedgehog (Hh) pathway inhibitor that suppresses signaling through Shh (IC50=1.5 uM) without significantly affecting Wnt signaling (IC50>30 uM).
More description
|
|
| DC23762 | PDI inhibitor 16F16 Featured |
PDI inhibitor 16F16 is a protein disulfide isomerase (PDI) inhibitor, first identified in a screen for compounds that prevent apoptosis induced by mutant huntingtin protein. 16F16 not only suppressed apoptosis induced by the misfolded protein mutant hungtingtin, it also protected rat neurons from cell death triggered by Aβ peptide. The actions of this inhibitor helped to identify a new mechanism in which a cell death pathway is regulated by protein misfolding via PDI upregulation.
More description
|
|
| DC23706 | Netoglitazone(MCC 555) Featured |
Netoglitazone, also known as isaglitazone and MCC-555, is an agent belonging to the glitazone class of antidiabetic agents with antihyperglycemic activity. Netoglitazone exerts both peroxisome proliferator-activated receptor (PPAR) alpha and gamma agonist activity. Netoglitazone decreases bone formation and increases marrow adipocyte formation in vivo.MCC 555 (Isaglitazone.
More description
|
|
| DC23654 | Psora-4 Featured |
Psora-4 is a potent and selective Kv1.3 potassium channel blocker with EC50 of 3 nM.
More description
|
|
| DC23610 | CP-339818 hydrochloride Featured |
CP-339818 is a potent, selective, non-peptide KV1.3 channel antagonist with IC50 of 200 nM.
More description
|
|
| DC22761 | NCI-83633 Featured |
A small molecule inhibitor of PP2C that activates extensive 3' cleavage at a concentration 50-fold below that required by fluoride or CP..
More description
|
|
| DC22706 | BMY 45778 Featured |
A potent, non-prostanoid prostacyclin partial agonist that potently inhibits human (IC50=35 nM), rabbit (IC50=136 nM) and rat (IC50=1.3 uM) platelet aggregation.
More description
|
|
| DC22696 | BRL 44408 Featured |
A potent, selective α2A-adrenoceptor antagonist with Ki of 1.7 nM, 80-fold selectivity over α2B-adrenergic receptors.
More description
|
|
| DC12218 | Tetradecanoylcarnitine Featured |
Tetradecanoylcarnitine is a human carnitine involved in β-oxidation of long-chain fatty acids.
More description
|
|
| DC26120 | (Z)-4-hydroxy Tamoxifen Featured |
(Z)-4-hydroxy Tamoxifen is a major phase I metabolite of tamoxifen, a well-known estrogen receptor antagonist in breast but partial estrogen receptor agonist in endometrium.
More description
|
|
| DC21756 | IP6K1 inhibitor TNP Featured |
IP6K1 inhibitor TNP is a potent, selective inositol hexakisphosphate kinase IP6K with IC50 of 0.47 uM (IP6K1), does not inhibit either human or yeast Vip/PPIP5K.
More description
|
|
| DC21664 | SMIFH2 Featured |
SMIFH2 is a small molecule formin homology 2 domains inhibitor of formin-mediated actin assembly, targets formins from evolutionarily diverse organisms including yeast, nematode worm, and mice with IC50s of 5-15 uM.
More description
|
|
| DC21392 | NNC-711 Featured |
NNC-711 is a potent and selective inhibitor of GABA uptake by GAT-1 with IC50 of 0.04 uM.
More description
|
|
| DC46977 | Polyvinylimidazole |
Polyvinylimidazole (Vimdemer) is a weak basic polyelectrolyte and has been already used as a model polyelectrolyte to study adsorption properties on various minerals.
More description
|
|
| DC46976 | Ganosporeric acid A |
Ganosporeric acid A, a natural product, is isolated from the ether-soluble fraction of the spores of Ganoderma lucidum (Curt.: Fr.) P. Karst. Ganosporeric acid A can be used for the research of liver injury.
More description
|
|